TZIELD (teplizumab) and the Risk of Viral Reactivation
New safety information - Adverse reaction - Product safety
Read the official notice →- Date
- 2026-09-14
- Country
- Canada
- Product
- TZIELD, teplizumab for injection, 2 mg per 2 mL (1 mg/mL) for intravenous infusion
- Category
- Drugs & medical
- Source
- Health Canada
Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.
Other drugs & medical recalls in Canada
- 2026-09-16
CA- CA
- 2026-09-15
- CA
Organika® Gummies: Foreign site not listed on site licence
Establishment/Site licensing
Health CanadaOfficial notice → - 2026-09-10
- CA
Generic acetaminophen by Teva recalled because it may contain foreign material
Contamination - Product quality
Health CanadaOfficial notice → - CA
- CA
Dxc 500i Clinical Analyzer and Dxc 500 AU Clinical Chemistry Analyzer
Performance
Health CanadaOfficial notice →